Recruitment

Recruitment Status
Completed

Inclusion Criteria

Untreated stage B or C chronic lymphocytic leukemia
Eligible for PET-CT
The subject must be covered by a social security system
...
Untreated stage B or C chronic lymphocytic leukemia
Eligible for PET-CT
The subject must be covered by a social security system
Adult over 18
Signed written informed consent
Untreated diffuse large B-cell lymphoma

Exclusion Criteria

Patients concurrently included in an investigational trial
immune hemolytic anemia
Age under 18
...
Patients concurrently included in an investigational trial
immune hemolytic anemia
Age under 18
Weight over 120 kg
active infectious disease
patients with creatinine clearance < 30 ml/mn
corticosteroid therapy
pregnant women

Summary

Conditions
Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients
Type
Interventional
Phase
Phase 1
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Diagnostic

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criteria

Untreated stage B or C chronic lymphocytic leukemia
Eligible for PET-CT
The subject must be covered by a social security system
...
Untreated stage B or C chronic lymphocytic leukemia
Eligible for PET-CT
The subject must be covered by a social security system
Adult over 18
Signed written informed consent
Untreated diffuse large B-cell lymphoma

Exclusion Criteria

Patients concurrently included in an investigational trial
immune hemolytic anemia
Age under 18
...
Patients concurrently included in an investigational trial
immune hemolytic anemia
Age under 18
Weight over 120 kg
active infectious disease
patients with creatinine clearance < 30 ml/mn
corticosteroid therapy
pregnant women

Tracking Information

NCT #
NCT02128945
Collaborators
CNRS, UMR ISTCT 6301, LDM-TEP Groupe, GIP Cyceron, Caen, France
Investigators
  • Principal Investigator: Sylvain P CHANTEPIE, MD University Hospital, Caen
  • Sylvain P CHANTEPIE, MD University Hospital, Caen